Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky
GeriPal
DECEMBER 15, 2022
Eric: So we’ve had an interesting topic today, storytelling and medicine, narrative medicine… We’ll talk about what we should call it, but before we do, Heather, I think you have a song request. Summary Transcript Summary. But wait, there’s a shiny new anti-amyloid drug, lecanemab! (No Transcript. Here we go.
105 
Let's personalize your content